Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: Methods/New Tools, Novel Tools and Methods

Application of Recombinant Rabies Virus to Xenopus Tadpole Brain

Regina L. Faulkner, Nicholas R. Wall, Edward M. Callaway and Hollis T. Cline
eNeuro 7 June 2021, 8 (4) ENEURO.0477-20.2021; https://doi.org/10.1523/ENEURO.0477-20.2021
Regina L. Faulkner
1Neuroscience Department and The Dorris Neuroscience Center, The Scripps Research Institute, La Jolla, CA 92037
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas R. Wall
2The Salk Institute for Biological Sciences, La Jolla, CA 92037
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward M. Callaway
2The Salk Institute for Biological Sciences, La Jolla, CA 92037
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Edward M. Callaway
Hollis T. Cline
1Neuroscience Department and The Dorris Neuroscience Center, The Scripps Research Institute, La Jolla, CA 92037
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hollis T. Cline
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Pseudotyped recombinant rabies virus infects tectal neurons in the Xenopus tadpole. A, Schematic of the labeling strategies using recombinant SAD B19 rabies virus which has the glycoprotein deleted and replaced by EGFP (SADΔG-EGFP), rendering it incapable of transneuronal spread. Infection with B19G phenotypically complemented virus (top) relies on endogenous expression of the B19G receptor. Infection with EnvA pseudotyped virus (bottom) requires exogenous expression of its receptor, TVA, before viral injection. Co-labeling TVA-transfected neurons with tRFP allows them to be identified. Viral injections were made in the optic tectum, which is marked by a dashed box in the drawing to the left. B, SADΔG-EGFP(B19G) virus infects tectal neurons. Confocal Z-projection collected in vivo through the injected optic tectal lobe shows widespread virally-mediated expression of EGFP in infected neurons. C, SADΔG-EGFP(EnvA) virus infects tectal neurons transfected with TVA. The right optic tectal lobe was transfected with CMV::TVA/tRFP by whole-brain electroporation and injected with SADΔG-EGFP(EnvA) virus 4 d later. Confocal Z-projections collected in vivo through the optic tectal lobe electroporated with CMV::TVA/tRFP (magenta) and injected with SADΔG-EGFP(EnvA) virus (green). Neurons which co-express TVA/tRFP and viral EGFP are marked by yellow arrows. The remaining EGFP-expressing neurons lack detectable tRFP expression and are presumably invisible TVA-expressing neurons. D, Viral infection efficiency varies with developmental stage. Tadpoles at stages 42–43 (n = 16 tadpoles), 44–45 (n = 28 tadpoles), or 46–48 (n = 65 tadpoles) were electroporated with CMV::TVA/tRFP using whole-brain electroporation. Four days later, the transfected tectal lobe was injected with SADΔG-EGFP(EnvA) virus. The percentage of animals with EGFP-expressing neurons was highest between stages 44 and 48. E, Infection with SADΔG-EGFP(EnvA) virus requires TVA. Confocal Z-projection collected in vivo through an optic tectal lobe injected with SADΔG-EGFP(EnvA) shows no infected neurons in the absence of TVA electroporation. F, SADΔG-EGFP(EnvA) infects tectal neurons transfected with TVA driven by the VGAT promoter. The right optic tectal lobe was transfected with VGAT::gal4, UAS::TVA, and UAS::tRFP by whole-brain electroporation and injected with SADΔG-EGFP(EnvA) virus 4 d later. Confocal Z-projections collected in vivo through the optic tectal lobe showing electroporated (magenta) and infected (green) tectal neurons. Neurons which co-express TVA/tRFP and viral EGFP are marked by yellow arrows. The remaining EGFP-expressing neurons lack detectable tRFP expression and are invisible TVA-expressing neurons. G, Quantification of the proportion of invisible TVA cells per animal with and without amplification. Amplifying tRFP expression using the gal4-UAS system decreases the proportion of infected, EGFP+ cells that lack detectable tRFP compared with tRFP driven by the CMV promoter without amplification. Data are presented as mean ± SEM overlaid with individual data points (***p < 0.0001, Mann–Whitney test). H, Targeted electroporation of TVA/tRFP does not eliminate invisible TVA-expressing neurons. Micropipette-mediated electroporation was used to limit transfection with TVA/tRFP to one or few neurons in the right optic tectal lobe. Four days later, the electroporated tectal lobe was injected with SADΔG-EGFP(EnvA) virus. Confocal Z-projection collected in vivo through the optic tectal lobe shows that EGFP-expressing infected neurons which lack detectable tRFP are still present. Scale bars: 50 μm.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Transcomplementation with rabies glycoprotein does not result in transneuronal spread of recombinant rabies in tadpoles. A, Schematic of the monosynaptic tracing strategy using SADΔG-EGFP(EnvA) virus with transcomplementation of rabies glycoprotein, B19G. Neurons co-transfected with TVA/tRFP and B19G can be directly infected by EnvA pseudotyped virus through the TVA receptor. Viral particles which bud from directly infected neurons will have B19G on their surface because B19G is provided in trans. In mammals, those viral particles can infect presynaptic neurons through the endogenous B19G receptor. Because presynaptically infected neurons lack B19G expression, viral particles generated in those neurons lack the glycoprotein and are not infectious, thereby prohibiting further spread. B, In vivo time-lapse imaging of infected tectal neurons from 3–6 d following injection of SADΔG-EGFP(EnvA) virus in the presence or absence of B19G. One tectal lobe was transfected with TVA/tRFP (magenta) alone (left) or with TVA/tRFP and B19G (right) and then injected with SADΔG-EGFP(EnvA) virus 4 d later. At 3 and 6 d after viral injection, confocal Z-stacks through the tectal lobe were collected. Z-projections show an increase in the number of EGFP+ neurons without detectable tRFP (white arrows) from 3 to 6 d after viral injection in both the presence and absence of B19G. Scale bar: 50 μm. C, Quantification of the average fold-change in the number of EGFP-only cells from 3 to 6 d after injection. There is a similar increase in the average number of EGFP-only cells over time in the presence (n = 17 tadpoles) and absence (n = 7 tadpoles) of B19G, suggesting a lack of local presynaptic spread of rabies virus. Data are presented as mean ± SEM overlaid with individual data points (p = 0.74, Mann–Whitney U test).

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Weak expression of B19G in vivo may explain the lack of transneuronal spread of rabies virus. A, B, Rabies glycoprotein is detected in the membrane fraction of transfected mammalian and Xenopus cell cultures by Western blotting. 293T (A) and XLK-WG Xenopus kidney cells (B) were transfected with B19G and proteins were extracted 24 h later. Membrane fractions were probed for B19G expression with anti-rabies glycoprotein antibody and β-tubulin acted as a loading control. Compared with untransfected cells, specific bands of ∼70 kDa were visible in transfected cells. Specific band in transfected XLK-WG cells is denoted by an arrow (B). C, Rabies glycoprotein is detected on the surface of Xenopus cells in vitro by immunocytochemistry. XLK-WG cells were transfected with GFP alone (top) or B19G and GFP (bottom). Confocal Z-projections of cells transfected with both B19G and GFP show surface expression of B19G by anti-rabies glycoprotein immunocytochemistry (magenta) without permeabilization. In contrast, no anti-rabies glycoprotein immunoreactivity is observed in cells transfected with GFP alone. Scale bar: 20 μm. D, Expression of B19G is very weak in vivo in tectal neurons. Tectal neurons were electroporated with CMV::B19G/tRFP, fixed 3–4 d later, and then immunohistochemistry with anti-rabies glycoprotein was performed. Confocal Z-projection of a 40-μm tissue slice shows very weak immunoreactivity for rabies glycoprotein (green) in B19G/tRFP expressing neurons (magenta). Scale bar: 50 μm.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Retrograde neuronal tracing using recombinant rabies virus. A, SADΔG-EGFP(B19G) virus retrogradely labels afferents to the injected target region. A montage of confocal Z-projections collected in vivo shows neurons infected by injection of SADΔG-EGFP(B19G) virus into the right tectal lobe. In addition to a large number of neurons expressing EGFP in the injected tectal lobe, retrogradely infected projection neurons are visible in the contralateral tectum, pretectum, and hindbrain. Tectal lobes are marked with dashed lines. Scale bar: 50 μm. B, A schematic which maps neurons labeled by unilateral tectal injection of SADΔG-EGFP(B19G) virus. Neurons in several regions known to project to the optic tectum are labeled. We also observed a large number of neurons in the injected tectal lobe and ipsilateral pretectum (green shading). AC, anterior commissure; FB, forebrain; HB, hindbrain; OT, optic tectum; PT, pretectum; V, ventricle. C, Retrograde viral tracing paired with immunohistochemistry reveals the cell types which project between the two tectal lobes. A montage of confocal Z-projections collected in vivo following injection of SADΔG-EGFP(B19G) virus into the right tectal lobe shows retrograde tracing of one intertectal neuron (boxed in left tectal lobe; i). Following fixation and tissue sectioning, immunohistochemistry was performed with an anti-GABA antibody to label inhibitory neurons. The EGFP+ neuron imaged in vivo (i) could be identified in fixed tissue slice (ii) and was GABA-negative (iii, magenta), suggesting that it is excitatory. Scale bars: 50 μm (i, ii) and 25 μm (iii). D, Schematic showing retrograde tracing strategy used in E. The left tectal lobe is electroporated with TVA/tRFP and 4 d later, SADΔG-EGFP(EnvA) virus is injected into the right tectal lobe. Expression of TVA on the surface of intertectal axons mediates viral infection of intertectal neurons in the left hemisphere. E, SADΔG-EGFP(EnvA) virus can be used to retrogradely trace neurons defined by anatomic location and axonal projections using promoter-driven expression of TVA. A montage of confocal Z-projections collected in vivo (i) demonstrate retrograde tracing of TVA-expressing neurons in the left tectal lobe (magenta) following injection of SADΔG-EGFP(EnvA) virus into the right tectal lobe. Retrogradely infected neurons (boxed in i) are shown at higher magnification (ii) and cells co-expressing EGFP and tRFP are marked by yellow arrows. Scale bars: 50 μm (i) and 25 μm (ii).

Tables

  • Figures
    • View popup
    Table 1

    Statistical table

    Data structureType of testp valueSample size (n = tadpoles)
    aFisher’s exact test0.3722°C n = 12
    28°C n = 11
    bFisher’s exact test0.63CMV::gal4 n = 4
    VGAT::gal4 n = 21
    cNot normally distributedMann–Whitney U test<0.0001gal4-UAS amplification n = 9
    No gal4-UAS amplification n = 14
    dNot normally distributedMann–Whitney U test0.74B19G+ n = 17
    B19G– n = 11
    • For each statistical test run in the study, the data structure, statistical test, p value, and sample size are listed.

Back to top

In this issue

eneuro: 8 (4)
eNeuro
Vol. 8, Issue 4
July/August 2021
  • Table of Contents
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Application of Recombinant Rabies Virus to Xenopus Tadpole Brain
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Application of Recombinant Rabies Virus to Xenopus Tadpole Brain
Regina L. Faulkner, Nicholas R. Wall, Edward M. Callaway, Hollis T. Cline
eNeuro 7 June 2021, 8 (4) ENEURO.0477-20.2021; DOI: 10.1523/ENEURO.0477-20.2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Application of Recombinant Rabies Virus to Xenopus Tadpole Brain
Regina L. Faulkner, Nicholas R. Wall, Edward M. Callaway, Hollis T. Cline
eNeuro 7 June 2021, 8 (4) ENEURO.0477-20.2021; DOI: 10.1523/ENEURO.0477-20.2021
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
    • Author Response
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • recombinant rabies virus
  • retrograde labeling
  • Xenopus
  • optic tectum
  • mesoscale connectomics

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: Methods/New Tools

  • Building an Ecosystem of Seizure Localization Methods: Neural Fragility as the First Step
  • Open-source platform for adjustable training regimes in freely moving and head-fixed mice
  • TriNet-MTL: A Multi-Branch Deep Learning Framework for Biometric Identification and Cognitive State Inference from Auditory-Evoked EEG
Show more Research Article: Methods/New Tools

Novel Tools and Methods

  • Building an Ecosystem of Seizure Localization Methods: Neural Fragility as the First Step
  • Open-source platform for adjustable training regimes in freely moving and head-fixed mice
  • TriNet-MTL: A Multi-Branch Deep Learning Framework for Biometric Identification and Cognitive State Inference from Auditory-Evoked EEG
Show more Novel Tools and Methods

Subjects

  • Novel Tools and Methods
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2026 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.